{"result": "(\"entity\"<|>ALIMENTOS<|>ORGANIZATION<|>Alimentos refers to food items that can impact health and nutrition, particularly in patients with specific dietary needs.)\n##\n(\"entity\"<|>DIETA HIPERPROTEICA<|>EVENT<|>Dieta hiperproteica is a high-protein diet that is not useful for maintaining glucose levels in certain patients.)\n##\n(\"entity\"<|>DISLIPEMIA<|>EVENT<|>Dislipemia refers to abnormal levels of lipids in the blood, which can be managed through dietary modifications.)\n##\n(\"entity\"<|>HIPERURICEMIA<|>EVENT<|>Hiperuricemia is a condition characterized by high levels of uric acid in the blood, often requiring dietary restrictions.)\n##\n(\"entity\"<|>ACIDOSIS LÁCTICA REFRACTARIA<|>EVENT<|>Acidosis láctica refractaria is a metabolic condition that may require specific dietary interventions.)\n##\n(\"relationship\"<|>ALIMENTOS<|>DIETA HIPERPROTEICA<|>Certain alimentos are not recommended in a dieta hiperproteica due to their impact on glucose levels<|>6)\n##\n(\"relationship\"<|>DISLIPEMIA<|>HIPERURICEMIA<|>Dislipemia and hiperuricemia are both conditions that can be managed through dietary changes<|>5)\n##\n(\"relationship\"<|>MCT<|>ACIDOSIS LÁCTICA REFRACTARIA<|>MCT supplementation can be beneficial in managing acidosis láctica refractaria<|>4)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Tema 14.     Soporte nutricional en patologías con alteración en el procesamiento…                      217\n\n\n\n       ciones de dextrinomaltosa, que se hidroliza exclu-                          MCT, y no hay seguimiento a largo plazo, por lo\n       sivamente en glucosa.                                                       que se requieren más estudios para confirmar los\n   •   Proteínas. En estos pacientes no es útil una dieta                          beneficios.\n       hiperproteica para mantener los niveles de gluce-                        •  Micronutrientes: Se recomienda la suplementa-\n       mia, ya que, como se ha dicho, también la gluco-                            ción de calcio, vitamina D y hierro.\n       neogénesis precisa de la acción de la Glu6Pasa en\n       su último paso para la transformación de Gluc-6-P                           –  Calcio y vitamina D, ya que estos pacientes tie-\n       en glucosa.                                                                    nen mayor riesgo de osteoporosis. Se debe su-\n       Las proteínas aportadas deben ser de alto valor                                plementar con calcio y vitamina D3 para cubrir\n       biológico, y se recomienda evitar aquellos ali-                                las RDA en función de la ingesta estimada con\n       mentos con alto contenido graso asociado. La                                   las fórmulas lácteas (tabla 3).\n       «leche» y las fórmulas lácteas a base de soja, li-                          –  Hierro. Se debe suplementar con el 100% de las\n       bres de lactosa y galactosa, pueden utilizarse                                 RDA ya que el almidón de maíz interfiere en su\n       desde la lactancia a la edad adulta para aportar                               absorción (tabla 3).\n       los HC y proteínas. En los niños mayores puede\n       introducirse leche de vaca (con lactosa) y sus de-                       •  Otros. Deben tratarse la dislipemia y la hiperuri-\n       rivados, aunque la cantidad máxima permitida                                cemia con las restricciones y consejos habituales\n       sería la equivalente, como hemos dicho, a un                                de estas patologías. No obstante, la hiperlipemia\n       vaso de leche desnatada, un yogur o 40 g de                                 responde solo parcialmente a las modificaciones\n       queso.                                                                      dietéticas y el tratamiento farmacológico.\n   •   Lípidos. Debe realizarse una dieta con un perfil                            Para evitar la nefrolitiasis y nefrocalcinosis se pue-\n       cardiosaludable, pobre en ácidos grasos satura-                             de alcalinizar la orina con suplementos de citrato\n       dos y rica en monoinsaturados, como se reco-                                potásico, aunque también es posible la utilización\n       mienda a la población general. Se han realizado                             de bicarbonato. Estos suplementos de citrato o\n       estudios con suplementación de triglicéridos de                             bicarbonato también son útiles en caso de acido-\n       cadena media (MCT) que mejoran la acidosis lác-                             sis láctica refractaria. En niños pequeños se reco-\n       tica y la hipertrigliceridemia al incrementar la oxi-                       mienda una dosis de 1 mg/kg/día dividida en\n       dación de ácidos grasos y disminuir la glucólisis.                          3 dosis, y monitorizar en función de la excreción\n       No obstante se incluyen grupos heterogéneos                                 urinaria de citrato. En niños mayores y adultos\n       de pacientes, diferentes indicaciones y tipos de                            se iniciará con 10 mEq tres veces al día. Se debe\n\n\n\nTabla 3.    Ingesta dietética recomendada (RDA) de calcio, vitamina D y hierro por edad y sexo.\n\n\n\n                                Calcio (mg/día)                        Vitamina D (UI/día)                          Hierro (mg/día)\n                           Mujeres              Varones              Mujeres              Varones              Mujeres              Varones\n  0-6 meses                  200*                  200*                 400                  400              0,27*                  0,27*\n  7-12 meses                 260*                  260*                 400                  400                 11                     11\n  1-3 años                   700                   700                  600                  600                  7                      7\n  4-8 años                 1000                  1000                   600                  600                 10                     10\n  9-13 años                1300                  1300                   600                  600                  8                      8\n  14-18 años               1300                  1300                   600                  600                 15                     11\n  19-50 años               1000                  1000                   600                  600                 18                      8\n  51-70 años               1200                  1000                   600                  600                  8                      8\n  > 70 años                1200                  1200                   800                  800                  8\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>MCT<|>ORGANIZATION<|>MCT refers to medium-chain triglycerides, which are dietary fats that can improve certain metabolic conditions.)\n##\n(\"entity\"<|>CALCIO<|>ORGANIZATION<|>Calcio is a mineral that is essential for bone health and is recommended for supplementation in patients at risk of osteoporosis.)\n##\n(\"entity\"<|>VITAMINA D<|>ORGANIZATION<|>Vitamin D is a nutrient that helps the body absorb calcium and is recommended for supplementation in patients at risk of osteoporosis.)\n##\n(\"entity\"<|>HIERRO<|>ORGANIZATION<|>Iron is a mineral that is important for blood health and is recommended for supplementation to prevent absorption issues in certain diets.)\n##\n(\"entity\"<|>NEFROLITIASIS<|>EVENT<|>Nefrolitiasis refers to the formation of kidney stones, which can be influenced by dietary factors.)\n##\n(\"entity\"<|>NEFROCALCINOSIS<|>EVENT<|>Nefrocalcinosis is a condition characterized by calcium deposits in the kidneys, which can be managed through dietary modifications.)\n##\n(\"relationship\"<|>MCT<|>CALCIO<|>MCT supplementation can help improve metabolic conditions that may also require calcium supplementation for bone health<|>3)\n##\n(\"relationship\"<|>MCT<|>VITAMINA D<|>MCT supplementation may be beneficial in patients who also need vitamin D for better calcium absorption<|>3)\n##\n(\"relationship\"<|>CALCIO<|>VITAMINA D<|>Calcium and vitamin D are often recommended together to enhance bone health and prevent osteoporosis<|>8)\n##\n(\"relationship\"<|>CALCIO<|>HIERRO<|>Calcium supplementation is important for patients who may also need iron to prevent absorption issues<|>4)\n##\n(\"relationship\"<|>VITAMINA D<|>HIERRO<|>Vitamin D is important for overall health and may support iron absorption in the body<|>4)\n##\n(\"relationship\"<|>NEFROLITIASIS<|>NEFROCALCINOSIS<|>Nefrolitiasis and nefrocalcinosis are related conditions that can be influenced by dietary factors<|>5)\n<|COMPLETE|>"}]}